Techmer PM Introduces HiFill® GF-PET Material System to Bridge Gap Between Low and High Temperature Tooling Requirements, Filling a Critical Need
As industries push toward more efficient and scalable composite part production, manufacturers face limited material choices for tooling that must perform reliably under autoclave conditions without exceeding budget constraints. The HiFill GF-PET fills this gap, delivering thermal stability and dimensional accuracy at an accessible cost, making it ideal for intermediate temperature tooling applications needed in the marine, automotive, wind, and aerospace industries.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
2 hours ago
- Toronto Star
Premier Health Reports 2025 Third Quarter Results
MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the 'Company'), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD&A for its third quarter ended on June 30, 2025. (1) See the Company's MD&A for details on these non-GAAP measures.
Toronto Star
2 hours ago
- Toronto Star
Cyber A.I. Group and Synergy Associates Form Strategic Joint Venture to Beta Test CyberAI Sentinel 2.0 Platform
MIAMI and NEW YORK and LONDON, Aug. 21, 2025 (GLOBE NEWSWIRE) — Cyber A.I. Group, Inc. ('CyberAI' or the 'Company'), an emerging growth Cybersecurity, Artificial Intelligence and IT services company engaged in the development of next-generation market disruptive AI-driven Cybersecurity technology, today announced it has entered into a strategic joint venture agreement with London-based Synergy Associates Ltd ('Synergy'), a leading global IT Managed Services Provider with operations in London, New York, Los Angeles, Paris, Hong Kong and Dubai. The partnership will center on the Beta testing and pre-commercial deployment of CyberAI's patent-pending CyberAI Sentinel 2.0 advanced AI-driven cybersecurity platform—which is designed to deliver autonomous threat detection, adaptive risk mitigation and intelligent system resilience to enterprise and cloud environments. The patent for CyberAI Sentinel 2.0 was filed with the United States Patent and Trademark Office on July 11, 2025.
Toronto Star
2 hours ago
- Toronto Star
BioSyent Declares Third Quarter 2025 Dividend
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. ('BioSyent', 'the Company', TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. This third quarter 2025 dividend compares with the second quarter 2025 dividend of $0.05 per common share. This dividend qualifies as an 'eligible dividend' for Canadian income tax purposes. The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors.
